Conversely, a previous report described that the proportion of CD34+ bone marrow progenitor cells increase after the anti-TNF-α treatment in RA patients, with the number of bone marrow mononuclear cells in clonogenic assays being higher when compared to the pretreatment values [67]. Here, CD34 is linked to rheumatoid arthritis.